Glastra Matthijs 4
4 · NOVANTA INC · Filed Feb 4, 2026
Research Summary
AI-generated summary of this filing
Novanta (NOVT) CEO Matthijs Glastra Sells Shares
What Happened
Matthijs Glastra, CEO of Novanta Inc. (NOVT), sold a total of 6,500 shares in open-market transactions on February 2, 2026, generating approximately $878,458 in proceeds. The sales were executed in four tranches: 3,606 shares @ $134.52 ($485,079), 1,738 shares @ $135.50 ($235,499), 1,108 shares @ $136.54 ($151,286), and 48 shares @ $137.38 ($6,594). These were disposals (sales), which are commonly routine and do not necessarily indicate a change in company outlook.
Key Details
- Transaction date: February 2, 2026; Form 4 filed February 4, 2026 (filed within the normal 2-business-day window).
- Tranche prices and notes:
- 3,606 sh @ $134.52 (weighted avg; actual trades ranged $133.96–$134.95).
- 1,738 sh @ $135.50 (weighted avg; actual trades ranged $134.98–$135.93).
- 1,108 sh @ $136.54 (weighted avg; actual trades ranged $136.02–$136.92).
- 48 sh @ $137.38 (weighted avg; actual trades ranged $137.29–$137.45).
- Total shares sold: 6,500; total proceeds: ~$878,458.
- Shares owned after transaction: Not reported in the provided Form 4 summary.
- Notable footnotes: Sales were executed pursuant to a pre-established Rule 10b5-1 trading plan adopted Sept 11, 2025 via a trust for which the reporting person's spouse is trustee. Reporting person committed to provide detailed trade-level info on request. Power of Attorney on file.
Context
The trades were made under a 10b5-1 plan (pre-set instructions), which is intended to prevent trading based on inside information. Sales under such plans are often routine portfolio-management actions. Because these are sales (not purchases or option exercises), they are less commonly interpreted as a bullish signal by investors.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-02-02$134.52/sh−3,606$485,079→ 67,761 total - Sale
Common Stock
[F1][F3]2026-02-02$135.50/sh−1,738$235,499→ 66,023 total - Sale
Common Stock
[F1][F4]2026-02-02$136.54/sh−1,108$151,286→ 64,915 total - Sale
Common Stock
[F1][F5]2026-02-02$137.38/sh−48$6,594→ 64,867 total
- 54,382(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.
- [F2]This transaction was executed in multiple trades ranging from $133.96 to $134.95. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades ranging from $134.98 to $135.93. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades ranging from $136.02 to $136.92. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]This transaction was executed in multiple trades ranging from $137.29 to $137.45. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.